Adam Cooper
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 7
- Cancer Cells and Metastasis 5
- Colorectal Cancer Treatments and Studies 4
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Matteo S. Carlino (8 shared papers)Georgina V. Long (5 shared papers)Paul de Souza (14 shared papers)Richard A. Scolyer (2 shared papers)Richard Kefford (5 shared papers)Benjamin Y. Kong (3 shared papers)Alexander M. Menzies (4 shared papers)Elizabeth Liniker (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (4 papers)Cancer Immunology Immunotherapy (2 papers)JNCI Cancer Spectrum (2 papers)Oncotarget (1 paper)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Adam Cooper
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Oncology 579
- Cancer Research 281
- Immunology 251
- Genetics 80
- Pulmonary and Respiratory Medicine 203
Countries citing papers authored by Adam Cooper
This map shows the geographic impact of Adam Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Cooper more than expected).
Fields of papers citing papers by Adam Cooper
This network shows the impact of papers produced by Adam Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Cooper. The network helps show where Adam Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 267 | |
| 2 | 2017 | 199 | |
| 3 | 2016 | 131 | |
| 4 | 2015 | 66 | |
| 5 | 2019 | 57 | |
| 6 | 2021 | 46 | |
| 7 | 2017 | 41 | |
| 8 | 2019 | 37 | |
| 9 | 2020 | 33 | |
| 10 | 2021 | 29 | |
| 11 | 2007 | 28 | |
| 12 | 2019 | 24 | |
| 13 | 2018 | 23 | |
| 14 | 2023 | 20 | |
| 15 | 2016 | 20 | |
| 16 | 2020 | 18 | |
| 17 | 2022 | 14 | |
| 18 | 2014 | 13 | |
| 19 | 2014 | 13 | |
| 20 | 2015 | 8 |
About Adam Cooper
Adam Cooper is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (579 citations), Cancer Research (281 citations), Immunology (251 citations), Genetics (80 citations) and Pulmonary and Respiratory Medicine (203 citations). Adam Cooper has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Matteo S. Carlino, Georgina V. Long, Paul de Souza, Richard A. Scolyer, Richard Kefford, Benjamin Y. Kong, Alexander M. Menzies, Elizabeth Liniker, Serigne Lo and Alexander Guminski. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Immunology Immunotherapy, JNCI Cancer Spectrum and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.